Novel aspects of eicosanoid signaling through the use of gene-targeted mice

References

• ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction ISIS-2. Lancet 1988; ii: 349–60.
   Google Scholar
• DienerHCCunhaLForbesCSiveniusJSmetsPLowenthalA. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeJ Neurol Sci1996143113
   PubMed Web of Science ®Google Scholar
• CAST (Chinese Acute Stroke Trial). Collaborative Group, CAST randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641–9.
   Google Scholar
• SanmuganathanPSGhahramaniPJacksonPRWallisEJRamsayLE. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trialsHeart20018526571
   PubMed Web of Science ®Google Scholar
• PatronoCCollerBDalenJEFitzGeraldGAFusterVGentM Platelet-active drugs: the relationships among dose, effectiveness, and side effectsChest20011193963S
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med 2002;136:157–60.
   Google Scholar
• SmithWLDeWittDLGaravitoRM. Cyclooxygenases: structural, cellular, and molecular biologyAnnu Rev Biochem20006914582
   PubMed Web of Science ®Google Scholar
• YuYChengYFanJChenXSKlein-SzantoAFitzGeraldGA Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturitionJ Clin Invest200511598695
   PubMed Web of Science ®Google Scholar
• ChengYWangMYuYLawsonJFunkCDFitzGeraldGA. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular functionJ Clin Invest200611613919
   PubMed Web of Science ®Google Scholar
• Yu Y, Fan J, Chen XS, Wang D, Klein-Szanto AJ, Campbell RL, . Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. Nat Med 2006;12699–704.
   Google Scholar
• CarmelietPFerreiraVBreierGPollefeytSKieckensLGertsensteinM Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature19963804359
   PubMed Web of Science ®Google Scholar
• MeyersENLewandoskiMMartinGR. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombinationNat Genet19981813641
   PubMed Web of Science ®Google Scholar
• NagyAMoensCIvanyiEPawlingJGertsensteinMHadjantonakisAK Dissecting the role of N-myc in development using a single targeting vector to generate a series of allelesCurr Biol199886614
   PubMed Web of Science ®Google Scholar
• CatellaFFitzGeraldGA. Paired analysis of urinary thromboxane B2 metabolites in humansThromb Res19874764756
   PubMed Web of Science ®Google Scholar
• ReillyIAFitzGeraldGA. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugsBlood1987691806
   PubMed Web of Science ®Google Scholar
• GrossGAImamuraTLuedkeCVogtSKOlsonLMNelsonDM Opposing actions of prostaglandins and oxytocin determine the onset of murine laborProc Natl Acad Sci U S A199895118759
   PubMed Web of Science ®Google Scholar
• HortonEWPoyserNL. Uterine luteolytic hormone: a physiological role for prostaglandin F2αPhysiol Rev197656595651
   Web of Science ®Google Scholar
• SugimotoYYamasakiASegiETsuboiKAzeYNishimuraT Failure of parturition in mice lacking the prostaglandin F receptorScience19972776813
   PubMed Web of Science ®Google Scholar
• ShimokawaTKulmaczRJDeWittDLSmithWL. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysisJ Biol Chem1990265200736
   PubMed Web of Science ®Google Scholar
• GrosserTFriesSFitzGeraldGA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunitiesJ Clin Invest2006116415
   PubMed Web of Science ®Google Scholar
• McAdamBFCatella-LawsonFMardiniIAKapoorSLawsonJAFitzGeraldGA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2Proc Natl Acad Sci U S A1999962727
   PubMed Web of Science ®Google Scholar
• ArmstrongEPMaloneDC. The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agentsClin Ther200325118
   Web of Science ®Google Scholar
• CurhanGCWillettWCRosnerBStampferMJ. Frequency of analgesic use and risk of hypertension in younger womenArch Intern Med200216222048
   PubMed Web of Science ®Google Scholar
• FrishmanWH. Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edemaAm J Cardiol2002891825D
   PubMed Web of Science ®Google Scholar
• Catella-LawsonFMcAdamBMorrisonBWKapoorSKujubuDAntesLLasseterKC Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoidsJ Pharmacol Exp Ther199928973541
   PubMed Web of Science ®Google Scholar
• SmithGC. The pharmacology of the ductus arteriosusPharmacol Rev1998503558
   PubMed Web of Science ®Google Scholar
• LoftinCDTrivediDBTianoHFClarkJALeeCAEpsteinJA Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2Proc Natl Acad Sci U S A200198105964
   PubMed Web of Science ®Google Scholar
• NguyenMCamenischTSnouwaertJNHicksECoffmanTMAndersonPA The prostaglandin receptor EP4 triggers remodeling of the cardiovascular system at birthNature19973907881
   PubMed Web of Science ®Google Scholar